Dawson, N <br/><br/>
Phase II study of suramin plus aminoglutethimide in two cohorts of patients with androgen-independent prostate cancer: simultaneous antiandrogen withdrawal and prior antiandrogen withdrawal.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Jan 1998 
 - 37-44 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Aminoglutethimide--administration & dosage<br/>Androgen Antagonists--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Humans<br/>Male<br/>Middle Aged<br/>Prostatic Neoplasms--drug therapy<br/>Suramin--administration & dosage<br/>Survival Rate